Join
Live feed
·
PRReleasevia Quantisnow
Oxford Immunotec Global PLC logo
PerkinElmer Inc. logo

Oxford Immunotec Submits Emergency Use Authorization Request to the FDA and CE Marks T-SPOT®.COVID, a Test for the Detection of a Cell Mediated (T cell) Immune Response to SARS-CoV-2 Infection

ByQuantisnow·Wall Street's wire, on your screen.
OXFD· Oxford Immunotec Global PLCPKI· PerkinElmer Inc.
Health CareIndustrials
Free account required

Sign up free to keep reading

Create a free Quantisnow account to read full insights, follow tickers, and get real-time alerts on filings, ratings, and regulatory news.

Sign up freeLog inNo credit card
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track OXFD (Oxford Immunotec Global PLC), PKI (PerkinElmer Inc.) and more on Quantisnow.